Structural Brain Imaging Phenotypes of Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) Found by

Mikko Kärkkäinen1, Mithilesh Prakash1, Marzieh Zare2

  • 1A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Insights

Hierarchical clustering of brain MRIs revealed distinct Alzheimer's disease (AD) subtypes and diverse patterns in mild cognitive impairment (MCI). This method effectively categorizes individuals based on brain atrophy, aiding in understanding disease progression.

Area of Science:

  • Neuroimaging
  • Neurology
  • Computational Biology

Background:

  • Alzheimer's disease (AD) and mild cognitive impairment (MCI) exhibit significant heterogeneity.
  • Understanding structural brain differences is crucial for diagnosis and prognosis.

Purpose of the Study:

  • To apply hierarchical clustering to magnetic resonance imaging (MRI) data to identify distinct structural phenotypes in subjects with MCI, AD, and normal controls (NC).
  • To investigate the relationship between identified clusters and disease progression.

Main Methods:

  • Hierarchical clustering algorithm applied to preprocessed gray matter density maps from 751 MCI, 282 AD, and 428 NC subjects.
  • Gray matter density maps were adjusted for age, gender, and education before clustering.
  • Longitudinal follow-up data (36 months) including ADAS slopes were used to assess progression rates.

Main Results:

  • Identified clusters corresponding to typical AD, atypical AD, limbic-predominant AD, and early-onset AD (EOAD).
  • EOAD subjects showed significant cortical gray matter atrophy, precuneus atrophy, and the highest progression rates.
  • MCI subjects displayed marked heterogeneity, including stable MCI, rapidly progressing diffuse atrophy, and patterns mimicking AD subtypes.
  • Bidirectional structural differences were observed in MCI subjects involving the anterior cerebellum and frontal cortex.

Conclusions:

  • Hierarchical agglomerative clustering is an effective tool for stratifying subjects with gray matter atrophy into clinically relevant structural phenotypes.
  • The observed diversity in MCI structural phenotypes warrants further investigation with larger cohorts.
  • This approach can aid in a more nuanced understanding of neurodegenerative disease progression.